Cost - effectiveness Analysis of Levof loxacin in Treating Lower Respiratory Tract Infections: Survey of 2 Dose Regimen
- VernacularTitle:左氧氟沙星2种给药方案治疗下呼吸道感染的成本-效果分析
- Author:
Jie LUAN
;
Xiaohui WANG
;
Ying TANG
;
Shouchun WANG
;
Kaiying SI
- Publication Type:Journal Article
- Keywords:
Levofloxacin;
Sequential therapy;
Injection treatment;
Lower respiratory tract infections;
Cost - effectiveness analysis
- From:
China Pharmacy
2005;0(21):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05), respectively; the costs were 640.50yuan and 1 151.21yuan, respectively; the cost-effectiveness ratios were 7.01 and 12.28, respectively; the incremental cost-effectiveness ratio of Group B versus Group A was 220.1. CONCLUSION: The sequential therapy of levofloxacin is preferable in the treatment of lower respiratory infection.
